Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity

Shuo Wang; Heinz Schättler

doi:10.3934/mbe.2016040

journal article Aug 01, 2016

Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity

Shuo Wang

Heinz Schättler

Mathematical Biosciences and Engineering Vol. 13 No. 6 pp. 1223-1240 · American Institute of Mathematical Sciences (AIMS)

View at Publisher Save 10.3934/mbe.2016040

Topics

No keywords indexed for this article. Browse by subject →

References

25

[1]

N. André "Metronomic scheduling of anticancer treatment: The next generation of multitarget therapy?," Future Oncology (2011) 10.2217/fon.11.11

[2]

B. Bonnard "Singular Trajectories and their Role in Control Theory," Springer Verlag (2003)

[3]

A. Bressan "Introduction to the Mathematical Theory of Control," American Institute of Mathematical Sciences (2007)

[4]

A. Ergun "Optimal scheduling of radiotherapy and angiogenic inhibitors," Bull. of Math. Biology (2003) 10.1016/s0092-8240(03)00006-5

[5]

Adaptive Therapy

Robert A. Gatenby, Ariosto S. Silva, Robert J. Gillies et al.

Cancer Research 2009 10.1158/0008-5472.can-08-3658

[6]

R. A. Gatenby "A change of strategy in the war on cancer," Nature (2009) 10.1038/459508a

[7]

J. H. Goldie "Drug resistance in cancer: A perspective," Cancer and Metastasis Review (2001) 10.1017/cbo9780511666544

[8]

J. H. Goldie "A model for resistance of tumor cells to cancer chemotherapeutic agents," Mathematical Biosciences (1983) 10.1016/0025-5564(83)90066-4

[9]

R. Grantab "The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells," Cancer Research (2006) 10.1158/0008-5472.can-05-3077

[10]

J. Greene "The impact of cell density and mutations in a model of multidrug resistance in solid tumors," Bull. Math. Biol. (2014) 10.1007/s11538-014-9936-8

[11]

O. Lavi "The role of cell density and intratumoral heterogeneity in multidrug resistance," Cancer Research (2013) 10.1158/0008-5472.can-13-1768

[12]

U. Ledzewicz "Minimizing tumor volume for a mathematical model of anti-angiogenesis with linear pharmacokinetics," in Recent Advances in Optimization and its Applications in Engineering (2010) 10.1007/978-3-642-12598-0_23

[13]

U. Ledzewicz "The influence of PK/PD on the structure of optimal control in cancer chemotherapy models," Mathematical Biosciences and Engineering (MBE) (2005) 10.3934/mbe.2005.2.561

[14]

U. Ledzewicz "Antiangiogenic therapy in cancer treatment as an optimal control problem," SIAM J. Contr. Optim. (2007) 10.1137/060665294

[15]

U. Ledzewicz "Singular controls and chattering arcs in optimal control problems arising in biomedicine," Control and Cybernetics (2009)

[16]

J. S. Li "Ensemble control of linear systems," Proc. of the 46th IEEE Conference on Decision and Control (2007)

[17]

J. S. Li "Ensemble control of Bloch equations," IEEE Transactions on Automatic Control (2009) 10.1109/tac.2009.2012983

[18]

A. Lorz "Population adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies," ESAIM: Mathematical Modelling and Numerical Analysis (2013) 10.1051/m2an/2012031

[19]

Modeling the Effects of Space Structure and Combination Therapies on Phenotypic Heterogeneity and Drug Resistance in Solid Tumors

Alexander Lorz, Tommaso Lorenzi, Jean Clairambault et al.

Bulletin of Mathematical Biology 2015 10.1007/s11538-014-0046-4

[20]

L. Norton "Tumor size, sensitivity to therapy, and design of treatment schedules," Cancer Treatment Reports (1977)

[21]

L. Norton "The Norton-Simon hypothesis revisited," Cancer Treatment Reports (1986)

[22]

E. Pasquier "Metronomic chemotherapy: New rationale for new directions," Nature Reviews|Clinical Oncology (2010) 10.1038/nrclinonc.2010.82

[23]

L. S. Pontryagin "The Mathematical Theory of Optimal Processes," Macmillan (1964)

[24]

H. Schättler "Geometric Optimal Control: Theory, Methods and Examples," Springer (2012) 10.1007/978-1-4614-3834-2

[25]

H. Schättler "Optimal Control for Mathematical Models of Cancer Therapies," Springer (2015) 10.1007/978-1-4939-2972-6

Cited By

35

Control Theory and Cancer Chemotherapy: How They Interact

Paola Lecca · 2021

Frontiers in Bioengineering and Bio...

Metrics

35

Citations

25

References

Details

Published: Aug 01, 2016
Vol/Issue: 13(6)
Pages: 1223-1240

Authors

S

Shuo Wang

The Molecular Foundry; Lawrence Berkeley National Laboratory; Berkeley; USA

H

Heinz Schättler

Cite This Article

Shuo Wang, Heinz Schättler (2016). Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity. Mathematical Biosciences and Engineering, 13(6), 1223-1240. https://doi.org/10.3934/mbe.2016040

Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity

You May Also Like